Latest chronic pain Stories

Large-Scale Meta-Analysis Shows Age Not a Social Barrier to Opioid Use and Misuse

2012-05-17 06:25:33

BALTIMORE, May 17, 2012 /PRNewswire/ -- Ameritox (SM), the nation's leader in pain medication monitoring, announced today the presentation of a peer-reviewed scientific poster titled "Patterns of Drug Use in the Older Chronic Pain Population" at the American Pain Society Annual Meeting. Ameritox researchers will share analysis from 725,679 urine drug monitoring samples from chronic pain patients aged 50 and older. Data show almost one-third (31.8 percent) lacked the...

The Illinois Back Institute Helps Patient Beat Debilitating Back Pain

2012-05-16 10:24:34

CHICAGO, May 16, 2012 /PRNewswire-iReach/ -- Chronic pain is terrifying. Sciatica and stenosis are two of the most common causes of persistent, debilitating back pain. Chicago resident Pedro Estrada suffered from extreme back pain that compromised his livelihood and soured his outlook on life. After taking time off from his job and consulting many doctors, he finally found relief with non-surgical treatment at the Illinois Back Institute. (Photo:...

Millennium Laboratories Sponsors Symposium on Managing Risk and Optimizing

2012-05-16 02:30:37

SAN DIEGO, May 16, 2012 /PRNewswire/ -- The prevalence of chronic pain in the United States continues to be significant with millions of patients impacted, yet under-treatment continues to be a problem. An educational luncheon sponsored by Millennium Laboratories at the upcoming Florida Society of Interventional Pain Physicians (FSIPP) Annual Meeting will look at the occurrence of chronic pain and substance abuse and address the principals of safe opioid prescribing, including...

Millennium Laboratories Sponsors Physician Education Programming at 31st Annual American Pain Society Meeting

2012-05-16 02:29:38

SAN DIEGO, May 16, 2012 /PRNewswire/ -- Millennium Laboratories, the leading research-based clinical diagnostic company dedicated to improving the lives of people suffering from pain, announced today that it is a sponsor of a corporate showcase presentation at the 31st Annual American Pain Society (APS) Meeting in Honolulu, HI. Millennium is also presenting new research findings, which may help physicians make clinical decisions about monitoring medication use as part of a...

BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its First Quarter 2012 Financials

2012-05-10 10:26:06

RALEIGH, N.C., May 10, 2012 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has filed its Quarterly Report on Form 10-Q for the quarter ended March 31, 2012, with the U.S. Securities and Exchange Commission. In connection therewith, BDSI is providing a review of its recent achievements in 2012 and an update on business operations and upcoming milestones for the balance of 2012. (Logo:...

Arthritis Is a Ridiculous Diagnosis, According to Top Pain Physician Tom Chi

2012-05-10 02:32:04

SOUTH FALLSBURG, N.Y., May 10, 2012 /PRNewswire/ -- Arthritis is a common diagnosis for pain; however, pain and arthritis are usually separate problems that coexist. The "death sentence" of arthritis as an incurable pain problem is a complete fallacy, says Tom Chi, a/k/a The Pain Whisperer. Medscape approximates 35% of Americans have chronic pain, and 50 million Americans are disabled partially or totally due to chronic pain. Dr. Hugh Rosomoff, MD, then chief of neurology at the...

WAISMANN METHOD® Medical Director Voices Support for Fibromyalgia Awareness Day

2012-05-09 14:23:28

BEVERLY HILLS, Calif., May 9, 2012 /PRNewswire/ -- Medical Director for WAISMANN METHOD® rapid opiate detox treatment and pain management specialist, Dr. Michael Lowenstein, announced his support for National Fibromyalgia Awareness Day, taking place on May 12, 2012. An increasing number of fibromyalgia patients are being prescribed opiate painkillers to address their chronic pain symptoms, which is alarming to Dr. Lowenstein as prescription painkiller use is also surging...

BioDelivery Sciences to Present at the Bank of America Merrill Lynch 2012 Healthcare Conference

2012-05-09 02:25:54

RALEIGH, N.C., May 9, 2012 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the Bank of America Merrill Lynch Healthcare Conference at Encore at the Wynn Hotel, Las Vegas, Nevada. The presentation is scheduled for Thursday, May 17, 2012 at 11:20 A.M. Pacific Time (2:20 P.M. Eastern Time). (Logo: http://photos.prnewswire.com/prnh/20110217/CL49801LOGO) Dr. Sirgo...

DURECT Announces Issuance of U.S. Patents Covering ORADUR® Technology

2012-05-03 02:32:18

CUPERTINO, Calif., May 3, 2012 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced the issuance of four patents by the United States Patent and Trademark Office (USPTO) covering DURECT's ORADUR technology. These patents provide additional intellectual property protection for REMOXY (oxycodone) Extended-Release Capsules CII and other ORADUR-based opioids until at least 2025. REMOXY, based on DURECT's ORADUR technology, is an investigational drug that is a unique,...

New Ameritox Rx Guardian INSIGHT(SM) Report Supports Improved Patient Care, Public Safety

2012-05-02 02:27:47

BALTIMORE, May 2, 2012 /PRNewswire/ -- Ameritox(SM), the nation's leader in Pain Medication Monitoring Solutions®, announced the official launch of its new Rx Guardian INSIGHT(SM)( )Report, a tool developed by Ameritox to help clinicians quickly assess five critical dimensions of medication adherence in patients with moderate to severe chronic pain. Chronic pain affects more than 50 million people in the United States. Opioid therapy provides needed relief to many patients, yet...